Aggarwal Vivek, Muthukrishnan J, Manrai Manish, Chauhan Premdeep, Vasdev Vivek
Associate Professor, Department of Internal Medicine, Armed Forces Medical College, Pune, India.
Senior Adviser (Medicine & Endocrinology), Base Hospital, Delhi Cantt, India.
Med J Armed Forces India. 2023 Mar-Apr;79(2):189-193. doi: 10.1016/j.mjafi.2021.03.011. Epub 2021 May 26.
Male osteoporosis is under-diagnosed and poorly studied. With the ageing population, osteoporotic fracture in men is an emerging health problem. The aim of this study was to study the prevalence of osteoporosis and its association with serum testosterone and serum vitamin D in elderly men (>60 years old) attending the outpatient department (OPD).
An observational cross-sectional study was performed in elderly men (>60 years old) attending OPD of a tertiary care hospital of Western Maharashtra between April 2017 and June 2019. Patients with rheumatological disorders, history of vertebral/femoral fractures, chronic kidney disease, chronic liver disease, thyroid disorders and alcohol dependence were excluded. Data were analysed using the chi-square test and descriptive statistics.
In total, 408 male patients were included. The mean age was 68.33 years. Osteoporosis was seen in 39.5% of patients (161/408) with a T score of ≤2.5. Osteopenia was noted in 48.3% of patients (197/408). T and Z scores had significant correlation (p = <0.001). Only 12% of elderly men had normal bone mineral density score. Serum testosterone, chronic obstructive pulmonary disease (COPD) and benign prostatic hypertrophy (BPH) were significantly associated with male osteoporosis with a p-value of 0.019, 0.016 and 0.010, respectively. Vitamin D levels, type 2 diabetes mellitus, hypertension and coronary artery disease did not show any significant association with male osteoporosis.
Osteoporosis was noted in 39.5% of the elderly men. In addition, decreased testosterone, COPD and BPH were significantly associated with male osteoporosis. It is important to screen elderly men to diagnose osteoporosis early and prevent osteoporotic fractures.
男性骨质疏松症的诊断不足且研究较少。随着人口老龄化,男性骨质疏松性骨折成为一个新出现的健康问题。本研究的目的是研究在门诊就诊的老年男性(>60岁)中骨质疏松症的患病率及其与血清睾酮和血清维生素D的关联。
于2017年4月至2019年6月在西马哈拉施特拉邦一家三级护理医院的门诊对老年男性(>60岁)进行了一项观察性横断面研究。排除患有风湿性疾病、有椎体/股骨骨折病史、慢性肾脏病、慢性肝病、甲状腺疾病和酒精依赖的患者。使用卡方检验和描述性统计进行数据分析。
共纳入408例男性患者。平均年龄为68.33岁。T评分≤2.5的患者中,39.5%(161/408)患有骨质疏松症。48.3%(197/408)的患者存在骨量减少。T值和Z值具有显著相关性(p = <0.001)。只有12%的老年男性骨密度评分正常。血清睾酮、慢性阻塞性肺疾病(COPD)和良性前列腺增生(BPH)与男性骨质疏松症显著相关,p值分别为0.019、0.016和0.010。维生素D水平、2型糖尿病、高血压和冠状动脉疾病与男性骨质疏松症未显示出任何显著关联。
39.5%的老年男性存在骨质疏松症。此外,睾酮降低、COPD和BPH与男性骨质疏松症显著相关。对老年男性进行筛查以早期诊断骨质疏松症并预防骨质疏松性骨折很重要。